United States · FDA National Drug Code directory
ABRAXANE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68817-134_d1c7770f-7099-4ad3-84e2-20e638cb224e
- Product NDC
- 68817-134
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Composition / generic term
- Paclitaxel
- Labeler
- Abraxis BioScience, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20050210
- Source listing expiry
- 20271231
Source-listed ingredients
- PACLITAXEL — 100 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (68817-134-50) / 20 mL in 1 VIAL, SINGLE-USE · 68817-134-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →